News

LevelJump Closes Private Placement Raising Gross Proceeds of over $877,000

Toronto, Ontario--(Newsfile Corp. - July 4, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the…

2 years ago

wellteq Digital Health Inc. Announces Director Resignation

Vancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - wellteq Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF), (the "Company" or…

2 years ago

Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update

Company also provides bi-weekly MCTO status updateVancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - Emerald Health Therapeutics, Inc. (CSE:…

2 years ago

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

GENEVA, SWITZERLAND / ACCESSWIRE / July 4, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), announced…

2 years ago

Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk

GENEVA, SWITZERLAND / ACCESSWIRE / July 4, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a…

2 years ago

ALK spotlights the impact of respiratory allergies on children at EAACI Congress

Four leading experts in respiratory allergy spotlight the impact of respiratory allergy in children, in an ALK-sponsored symposium at the…

2 years ago

VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors

Toronto, Ontario--(Newsfile Corp. - July 2, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO" or the "Company"), a…

2 years ago

Innovation Vista Named Most Promising Digital Transformation Firm

Los Angeles, California--(Newsfile Corp. - July 1, 2022) - CIO Review announces Innovation Vista as Most Promising Emerging Digital Transformation…

2 years ago

ClexBio Announces New Appointments to Board of Directors

OSLO, Norway & BOSTON--(BUSINESS WIRE)--ClexBio, an early-stage biotech company developing next-generation tissue engineered grafts for transplant, is announcing the appointment…

2 years ago

ProAssurance Second Quarter 2022 Results Release and Teleconference

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended June 30, 2022 after the close of normal…

2 years ago